Strengthening HCP Relationships Through Optimized Contracting Processes: Best Practices, LLC Study Offers Key Insights for Global Success
CHAPEL HILL, N.C., Oct. 11, 2024/ -- In today’s increasingly regulated healthcare landscape, biopharma and medical device companies are working to strengthen their relationships with Healthcare Providers (HCPs). Establishing compliant, effective HCP contracting processes has become critical for ensuring successful global engagements.
Best Practices, LLC, a leading research and consulting firm, conducted an in-depth study, engaging 20 biopharma organizations, to explore and benchmark the best practices for HCP contracting. The report, titled "HCP Engagement Excellence: Optimizing Contracting Processes, Resources, and Internal Interactions," provides actionable insights on streamlining timelines, optimizing resource allocation, and reducing contracting complexities.
Our research shows that Global US contracting for EU takes longer than US and Outside-EU/US contracting:
- Global US contracting for EU (On average, takes about 3 months from program approval to program execution for this type of HCP Contracting)
- US contracting (On average, takes about 2 months or less from program approval to program execution)
- Global US Contracting outside EU/US (On average, takes about 2 months or less from program approval to program execution)
Key topics include:
- Strategies for Reducing HCP Contracting Complexities
- Optimal Timelines and Resources
- Best Practices for Internal Coordination and Approvals
Ready to dive deeper? Download the complimentary report summary to gain deeper insights:
https://www.best-in-class.com/rw390.htm
Pressed for Time? Watch our video summary to learn how leading biopharma companies are successfully navigating the challenges of HCP contracting across global markets: